Nalbuphine Versus Ketamine for Prevention of Emergence Agitation After Sevoflurane in Children Undergoing Tonsillectomy

PHASE4CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

March 25, 2021

Primary Completion Date

June 25, 2021

Study Completion Date

June 25, 2021

Conditions
Pediatric ALLPediatric Anesthesia
Interventions
DRUG

Nalbuphine Injection

At the end of the surgery and just before discontinuation of sevoflurane and extubation the study medications will be prepared by the local pharmacy as 10 ml syringes that were handed to the anesthesiologist in charge in OR room who was blinded to the nature of the medications.

DRUG

Ketamine

At the end of the surgery and just before discontinuation of sevoflurane and extubation the study medications will be prepared by the local pharmacy as 10 ml syringes that were handed to the anesthesiologist in charge in OR room who was blinded to the nature of the medications.

DRUG

Saline

At the end of the surgery and just before discontinuation of sevoflurane and extubation the study medications will be prepared by the local pharmacy as 10 ml syringes that were handed to the anesthesiologist in charge in OR room who was blinded to the nature of the medications.

Trial Locations (1)

11591

Ain Shams university hospitals, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER

NCT05176119 - Nalbuphine Versus Ketamine for Prevention of Emergence Agitation After Sevoflurane in Children Undergoing Tonsillectomy | Biotech Hunter | Biotech Hunter